As cardiovascular physicians, we've all had patients who believe they are social drinkers but end up with cardiovascular complications. This raises some widely debated questions. What amount of alcohol is too much? Is alcohol truly cardioprotective? Should we recommend patients to start drinking in moderation or ask them to completely abstain?

The Foundations of the Alcohol-Heart Hypothesis

Early studies, including the Framingham Heart Study and the Physicians' Health Study, suggested cardioprotective effects of light to moderate alcohol consumption, particularly reduced coronary artery disease (CAD) and mortality.^1,2 Based on this and many other cohorts, the Dietary Guidelines Advisory Committee for Americans recommended limiting alcohol, if consumed, to ≤one drink a day for women and ≤two for men (about 14 grams of ethanol) in its 2020-2025 version³ and to drink less alcohol in its 2025-2030 version.

However, a peek beyond the coronaries is crucial to exploring alcohol's systemic cardiovascular footprint.

The Risk Factor Equation: Decoding Alcohol's Role

While studies have shown improvement in cardiovascular risk profile with light to moderate alcohol consumption, when quantified, these effects are relatively small.^4,5 Data showed that HDL increased by approximately 3 mg/dL (7%), while LDL, triglycerides and lipoprotein(a) decreased (3 mg/dL, 2.1% and 0.4%, respectively), while total cholesterol remained unchanged.⁶

Similarly, a meta-analysis of 14 interventional studies found that alcohol had a neutral effect on fasting glucose and insulin sensitivity but was associated with a reduction in hemoglobin A1c.⁶ Similar J-shaped association of alcohol and hypertension has been shown.^6,7

Across multiple cohorts, light consumption has been linked to lower cardiovascular risk, whereas higher intake is clearly associated with worsening hypertension.⁸ Whether such modest changes translate into meaningful clinical outcomes remains uncertain.

Beyond the Pipes: Alcohol's Influence From Pump to Periphery

Chronic heavy alcohol consumption is well established to cause dilated cardiomyopathy, cardiac arrhythmias like atrial fibrillation (AFib), atrial flutter and sudden cardiac death, and increased risk of stroke.^9-12

While multiple studies, including the Framingham Heart Study, suggested a protective or neutral effect of alcohol against cardiomyopathy, newer data in a population of 50,000 Koreans and in British men failed to demonstrate any favorable cardiovascular effects of low-moderate alcohol.^2,10,13

Recent data have strengthened the link between alcohol use and AFib episodes. Multiple case-control studies, and more recently I-STOP-AFib, have demonstrated a clear association between alcohol consumption and the occurrence of AFib.¹³ Notably, emerging evidence challenges the traditional view that only binge drinking precipitates AFib; showing instead that even a single alcoholic beverage may be sufficient to trigger an episode in individuals with established AFib.¹⁰

A 2011 meta-analysis of 84 studies reported a J-shaped association between alcohol intake and stroke risk, suggesting lower incidence with light to moderate drinking due to alcohol's antithrombotic effects.¹⁴ However, newer data indicate a dose-dependent increase in stroke risk, particularly beyond 100 g/week, supporting lower intake recommendations or abstinence for optimal health.^11,12 This is especially true with respect to hemorrhagic stroke which is more likely to occur even at low consumption levels, as opposed to ischemic stroke for which modest intake may confer limited protection.^8,11

Alcohol's relationship with peripheral artery disease (PAD) parallels that of CAD. Observational data suggest mild to moderate intake may correlate with lower PAD prevalence and mortality though the optimal dose remains unclear.^8,15 In the absence of randomized trials, these findings warrant caution, as higher consumption may adversely affect vascular health.

Current Evidence and Guidelines

Newer evidence on larger inclusive populations, individual participant-level data meta-analysis and Mendelian randomization have now shown no clinically significant benefit of alcohol on cardiovascular health.⁵ The Global Burden of Disease study of 2016, which analyzed data from 28 million participants in 195 countries noted the relative risk for all-cause mortality increased the moment patients started drinking even one drink per day.¹⁶

Even the Framingham Heart Study acknowledged that the statistically significant inverse link between alcohol use and CAD might have been overstated, as the large sample size could exaggerate modest associations.²

While the 2021 European Society of Cardiology prevention guideline has a class 1B recommendation of limiting alcohol to <100 grams/week, they mention that newer Mendelian randomization studies do not support the protective effects of alcohol, hinting at the lowest risk of cardiovascular disease in people who abstain from alcohol.¹⁷ The 2023 ACC/AHA guideline on chronic coronary disease has given a class 3 (no benefit) indication for patients with cardiac diseases to avoid consuming alcohol for the purpose of cardiovascular protection.¹⁸

Collectively, these observations advocate for prudent caution, especially among those who consume alcohol under the assumption of cardiovascular protection.

To Drink or Not to Drink: What Do We Tell Our Patients?

There is clear evidence that heavy and binge drinking increases risk of cardiovascular disease and its risk factors. Although observational studies have previously reported favorable effects of light drinking on cardiovascular risk profile, emerging data suggest there is optimal cardiovascular, oncologic and systemic protection with complete abstinence. While large-scale randomized trials are still needed to clarify the cardiovascular effects of drinking by accounting for individual variability in demographics, genetics, environmental factors and molecular mechanisms, the current message is unequivocal: no amount of alcohol promotes overall systemic health.

References

1. Gaziano JM, Gaziano TA, Glynn RJ, et al. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000;35(1):96-105.
2. Gordon T, Kannel WB. Drinking habits and cardiovascular disease: the Framingham Study. Am Heart J. 1983;105(4):667-73.
3. Dietary Guidelines for Americans, 2020-2025. US Department of Agriculture, US Department of Health and Human Services; 2020.
4. Chiva-Blanch G, Badimon L. Benefits and Risks of moderate alcohol consumption on cardiovascular disease: current findings and controversies. Nutrients. 2019;12(1).
5. Piano MR, Marcus GM, Aycock DM, et al. Alcohol use and cardiovascular disease: A Scientific Statement from the American Heart Association. Circulation. 2025;152(1):e7-e21.
6. Schrieks IC, Heil AL, Hendriks HF. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care. 2015;38(4):723-32.
7. Sesso HD, Cook NR, Buring JE. Alcohol consumption and the risk of hypertension in women and men. Hypertension. 2008;51(4):1080-7.
8. Piano MR. Alcohol's effects on the cardiovascular system. Alcohol Res. 2017;38(2):219-41.
9. Bozkurt B, Colvin M, Cook J, et al. Current Diagnostic and treatment strategies for specific dilated cardiomyopathies: A Scientific Statement from the American Heart Association. Circulation. 2016;134(23):e579-e646.
10. Wong CX, Tu SJ, Marcus GM. Alcohol and arrhythmias. JACC Clin Electrophysiol. 2023;9(2):266-79.
11. Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513-23.
12. Zhang C, Qin YY, Chen Q, et al. Alcohol intake and risk of stroke: a dose-response meta-analysis of prospective studies. Int J Cardiol. 2014;174(3):669-77.
13. Marcus GM, Modrow MF, Schmid CH, et al. Individualized studies of triggers of paroxysmal atrial fibrillation: The I-STOP-AFib randomized clinical trial. JAMA Cardiol. 2022;7(2):167-74.
14. Ronksley PE, Brien SE, Turner BJ. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
15. Garcia-Diaz AM, Marchena PJ, Toril J, et al. Alcohol consumption and outcome in stable outpatients with peripheral artery disease. J Vasc Surg. 2011;54(4):1081-7.
16. Collaborators GBDA. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015-35.
17. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed). 2022;75(5):429.
18. Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC guideline for the management of patients with chronic coronary disease: A rport of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 82(9):833-955.

Clinical Topics: Prevention

Keywords: Cardiology Magazine, ACC Publications, CM-Jun-2026, Alcohol Drinking, Binge Drinking, Health Risk Behaviors, Risk Factors, Secondary Prevention